https://www.pagepress.org/journals/dr/issue/feed Dermatology Reports 2024-06-18T08:46:43+00:00 Emanuela Fusinato emanuela.fusinato@pagepress.org Open Journal Systems <p><strong>Dermatology Reports </strong>is the Official Journal of the <em>Italian Association of Hospital Dermatologists</em> (ADOI - Associazione Dermatologi-Venereologi Ospedalieri Italiani e della sanità pubblica) of the <em>Italian Melanoma Intergroup</em> (IMI) and of the <em>Italian Society of Surgical Oncologic, Corrective and Aesthetic Dermatology</em> (SIDCO - Società Italiana Dermatologia Chirurgica Oncologica, Correttiva ed Estetica).</p> <p>Manuscripts dealing with research, biology, epidemiology, clinics of all skin-related diseases are welcome.<strong> Dermatology Reports</strong> publishes original articles, reviews, brief reports and case reports.</p> https://www.pagepress.org/journals/dr/article/view/9751 Association of recalcitrant scabies infestation and bullous pemphigoid in an infant 2024-06-18T08:46:43+00:00 Thilo Gambichler gambichler@me.com Rita Mansour rita.mansour@klinikum-bochum.de Tobias Rothoeft t.rothoeft@derma.de Enno Schmidt e.schmidt@derma.de Martin Doerler m.doerler@derma.de Laura Susok l.susok@derma.de <p>Dear Editor, In adults, bullous pemphigoid (BP) has been described in association with scabies. We here describe an infant with recalcitrant scabies who developed generalized BP as confirmed by serological and immunofluorescence studies. About four weeks after birth, an otherwise healthy non-vaccinated male infant was diagnosed with scabies. His parents and sister were diagnosed with scabies as well. [...]</p> 2024-06-18T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9734 Apalutamide-induced ichthyosiform eruption 2023-08-24T13:42:12+00:00 Christian Ciolfi chriciolfi96@gmail.com Anna Lunardon annalunardon16@gmail.com Fortunato Cassalia fortunato1287@gmail.com Mauro Alaibac mauro.alaibac@unipd.it <p>Dear Editor, Skin eruptions are commonly observed in patients undergoing anticancer therapy, and with the introduction of new drugs in the antitumor treatment landscape evidence regarding their potential cutaneous adverse effects is still building. We herein report the case of an acquired ichthyosiform reaction induced by apalutamide. [...]</p> 2023-08-24T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9763 COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports 2023-08-24T13:42:06+00:00 Angelo Massimiliano D'Erme a.m.derme@gmail.com Cristian Fidanzi cri.fidanzi@outlook.it Marco Romanelli a.m.derme@gmail.com Valentina Dini valentinadini74@gmail.com Giovanni Bagnoni giovanni.bagnoni@gmail.com Agata Janowska dottoressajanowska@gmail.com <p>Dear Editor, Chronic spontaneous urticaria (CSU) is an inflammatory skin disease characterized by itchy pomphi associated or not with angioedema and occurring with daily or near-daily frequency for more than six weeks. It is divided into two entities, an autoimmune form determined by the presence of immunoglobulin (IgG) specific for FcɛRI receptors on tissue mast cells and circulating basophils, and an idiopathic form. [...]</p> 2023-08-24T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9807 Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace 2023-08-24T14:17:50+00:00 Corrado Zengarini corrado.zengarini@yahoo.it Giacomo Clarizio giacomo.clarizio@studio.unibo.it Federico Bardazzi federico.bardazzi@aosp.bo.it Martina Mussi mussi.martina1809@gmail.com Carlotta Baraldi carlotta.baraldi@gmail.com Bianca Maria Piraccini biancamaria.piraccini@unibo.it Alessandro Pileri alessandro.pileri2@unibo.it <p>Dear Editor, We report the case of a 78-year-old Caucasian male examined in our dermatological unit for swelling of the right arm. He described an increase in right arm size, which had a slow and progressive growth over the last two years and a perception of skin hardening and difficulty in flexing and extending the joint. Moreover, he has been experiencing muscle pain during the previous eight months. [...]</p> 2023-08-24T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9803 Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion 2023-08-24T14:17:53+00:00 Gaia Fasano fasano.gaia@gmail.com Giancarlo Valenti gvalenti@aocz.it Domenico D'Amico domenicodamico@live.it Mario Valenti mario.valenti@hunimed.eu <p>The generalized and sclerodermic form of lichen myxedematosus, known as scleromyxedema (SMX), is a chronic mucinosis that manifests cutaneously and has multiple systemic comorbidities. There are few available treatment options and no established therapeutic guidelines. We describe a 48-year-old man who had intravenous immunoglobulins (IVIg), oral corticosteroids, and methotrexate (MTX) for the treatment of SMX, monoclonal gammopathy, and arthritis. Because of its effectiveness and high level of tolerance, IVIg is the most often used first-line therapy for SMX and has been used for an increasing range of skin conditions. In our instance, better control of skin disease and extracutaneous manifestations was made possible by combining IVIg with oral prednisone and MTX. To the best of our knowledge, this is the first instance of SMX treatment that has combined therapeutic approaches with a favorable safety profile.</p> 2023-08-24T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9770 Cutaneous tuberculosis, different clinical spectrum of the same disease: the importance of pre-test probability 2024-01-24T15:53:06+00:00 Carla Rosero carlirosero@gmail.com Lucy Baldeón lybaldeon@uce.edu.ec Valeria Alulema vealulema@uce.edu.ec Adriana Rueda aerueda@uce.edu.ec Lorena Vaca wilorenvp29@hotmail.com Daniela Galarza dannygalarza18@hotmail.com Cesar Prócel procelc@gmail.com <p>This report presents three cases of cutaneous tuberculosis that were identified at the Calderon Hospital in Quito, Ecuador. The first case involved a 44-year-old man who had tuberculosis verrucosa cutis, characterized by circinate erythematous areas, ulcerated nodules, and verruciform plaques extending from the right lower limb to the hip. In the second case a 50-year-old woman with a 1-year history of pruritic dermatosis in the left ciliary area was diagnosed with lupus vulgaris. In the third case, a 23-year-old man with erythematous nodules draining caseous material at the neck, thorax, and axillary region was diagnosed with scrofuloderma. It was discovered that nearly every laboratory test that was accessible had drawbacks as a diagnostic technique. Correlating clinical and epidemiological features with the pretest probability is crucial for optimizing indicators and confirming or ruling out the diagnosis in immunocompromised and high-risk individuals with atypical lesions.</p> 2024-01-24T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9720 Atypical facial pustular folliculitis by <i>Klebsiella pneumoniae</i>: a case report 2023-08-11T08:30:32+00:00 Mario Valenti mario.valenti@hunimed.eu Andrea Cortese andrea.cortese@humanitas.it Paola Facheris paola.facheris@humanitas.it Francesco Sacrini francesco.sacrini@humanitas.it Alessandra Narcisi alessandra.narcisi@humanitas.it Antonio Costanzo antionio.costanzo@hunimed.eu Luca Mancini luca.mancini@humanitas.it <p>Rarely, the gram-negative bacteria <em>Klebsiella pneumoniae</em> causes skin infections that are frequently challenging to identify. We present a case of an atypical presentation of this specific disease in terms of its site, lack of risk factors, and length of illness.</p> 2023-08-11T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9782 Deep mycosis mimicking cutaneous squamous cell carcinoma 2023-08-11T07:34:01+00:00 Fortunato Cassalia fortunato1287@gmail.com Francesco Gratteri francesco.gratteri@studenti.unipd.it Leonardo Azzi leonardoazzi30@gmail.com Anna L. Tosi annalisa.tosi@aulss5.veneto.it Mauro Giordani mauro.giordani@aulss5.veneto.it <p>Deep cutaneous mycoses (DCMs) and skin fungal infections can cause significant morbidity until diagnosed and treated. In immunocompromised people, <em>Candida</em> spp., <em>Aspergillus</em> spp., and <em>Fusarium</em> spp. fungi can cause these infections, but dermatophytes, especially <em>Trichophyton rubrum</em> and <em>T. mentagrophytes</em>, are the most common. Superficial erythematous lesions become firm subcutaneous nodules, ulcers, abscesses, or sinus tracts. In advanced cases, DCMs can cause osteomyelitis and bone loss. DCM included mycetoma, a chronic infectious disease of the skin, subcutaneous tissues, and bones. In some areas, it is endemic and can mimic cutaneous tuberculosis or cancerous lesions, making diagnosis difficult. Clinical presentation, radiological findings, and microbiological culture are used to diagnose with molecular methods helping in culture-negative cases. An immunocompetent farmer with a wrist lesion initially suspected as cutaneous squamous cell carcinoma was histologically diagnosed as eumycetoma, emphasizing the importance of considering deep mycoses in highrisk individuals and their heterogeneous clinical presentation.</p> 2023-08-11T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9779 Septic embolism due to periorbital cellulitis caused by pimple drainage 2023-08-09T14:00:05+00:00 Luis Carlos Restrepo Vanegas lcrvanegas@yahoo.es Alejandro Rojas Urrea arojasurrea.22@gmail.com Juan Manuel Corredor Torres corredorj103@gmail.com Lorena García Agudelo dr.lorenagarcia29@gmail.com Luis Carlos Avellaneda Curcho lavellaneda@unbosque.edu.co <p>Everyone has used homemade pimple drainage at some point in their lives, particularly in their adolescent and early adult years. However, pimple drainage should always be considered a mild medical procedure, especially in cases where the patient has serious skin diseases. We present the case of a 22-year-old female patient who, in the course of her routine, made a home pimple drainage that resulted in periorbital cellulitis and a septic embolism, despite the fact that these types of clinical cases are uncommon in routine medical practice. This case emphasizes how crucial it is to identify periorbital cellulitis early and treat it appropriately in order to stop a septic embolism from developing.</p> 2023-08-09T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9800 Delayed hypersensitivity reaction after hyaluronic acid filler (VCY-20) 2023-09-11T15:17:31+00:00 Patricio Mendoza-Gálvez patmen96@gmail.com Christopher Jesús del Rio-Martinez christodelrio@gmail.com Victoria Holguín-Montaño victoriaholguinemis@gmail.com Marcela Santos-Flores dramarce@yahoo.com <p>Hyaluronic acid (HA) filler, a transient injectable used for rejuvenating facial treatments, has become increasingly popular over time since it doesn’t require surgery. Although these procedures are generally safe, there are some application-related complications. These issues fall into three categories: reactions with early, delayed, or late onset. This case report features a 55-yearold female patient who developed widespread facial edema as a result of a delayed hypersensitivity reaction that happened after HA filler was applied.</p> 2023-09-11T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9771 Hydroxychloroquine-induced generalized myopathy in a patient with lupus tumidus: a case report 2023-10-17T08:11:13+00:00 Alice Verdelli alice.verdelli@hotmail.it Daniela Massi daniela.massi@unifi.it Vincenza Maio vincenza.maio@unifi.it Gabriele Cavazza gabriele.cavazza@unifi.it Alberto Corrà alberto.corra@unifi.it Elena Biancamaria Mariotti elenabiancamaria.mariotti@unifi.it Lavinia Quintarelli lavinia.quintarelli@gmail.com Valentina Ruffo Di Calabria valentina.ruffodicalabria@unifi.it Cristina Aimo cristina.aimo@unimi.it Emiliano Antiga emiliano.antiga@unifi.it Marzia Caproni marzia.caproni@unifi.it <p>A subtype of cutaneous lupus erythematosus known as lupus erythematosus tumidus (LET) is characterized by sun-exposed areas that typically display urticaria-like papules and plaques. For LET, systemic therapy with antimalarials – particularly hydroxychloroquine (HCQ) – is the first line of treatment. Even though the safety profile of these medications appears to be high, there have been very few reports of side effects in the literature, including hemolytic anemia, retinal toxicity, maculopapular rash, gastrointestinal disturbance, and blue-gray discoloration of the skin or mucous membranes. Here, we report a unique instance of a 46- year-old LET smoker who, following HCQ treatment, developed a generalized myopathy.</p> 2023-10-17T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9784 When the diagnosis is written in the DNA: a case of erythropoietic protoporphyria in a patient with a chromosome-18 deletion 2023-09-22T09:37:19+00:00 Sara Rovaris s.rovaris@unibs.it Giuseppe La Rosa g.larosa@unibs.it Sara Mezzana s.mezzana@unibs.it Francesco Tonon f.tonon@unibs.it Luigi Mori luigi.mori@unibs.it Eugenio Monti eugenio.monti@unibs.it Giuseppe Mazzeo giuseppe.mazzeo@unibs.it Piergiacomo Calzavara-Pinton piergiacomo.calzavarapinton@unibs.it Mariachiara Arisi mariachiara.arisi@gmail.com <p>In this case study, we describe a 21-year-old man with erythropoietic protoporphyria who sought medical attention in April 2022 for diffuse edema and erythema of the hands. These symptoms had been present since childhood and usually occurred soon after sun exposure. The patient’s medical history showed that chromosome 18’s long arm had partially deleted. We performed a number of tests, including measuring total erythrocyte protoporphyrin levels and utilizing a spectrofluorometer to assess the fluorometric emission peak of plasma porphyrins, based on the patient’s medical history and clinical symptoms. Furthermore, a genetic analysis identified an intronic variant on one allele, c.315-48T&gt;C (IVS3- 48T&gt;C), which is categorized as a susceptibility polymorphism, and a complete deletion of the ferrochelatase gene on the other allele. The patient’s clinical condition improved following the June 2022 afamelanotide implant procedure.</p> 2023-09-13T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9854 HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population 2023-10-16T13:49:01+00:00 Nhi Thi Uyen Pham drphamthiuyennhi@gmail.com Thuong Van Nguyen nguyenvanthuongdlvn@yahoo.com Hao Trong Nguyen bshao312@yahoo.com <p>Psoriasis is a chronic inflammatory skin disease that affects people all over the world. It is linked to the HLA-Cw6 allele, which is more common in Caucasians than in Asians and varies across ethnic groups. We investigated the association between the disease severity and the onset age of HLA-Cw6 prevalence in Vietnamese psoriasis patients. In 121 psoriasis patients and 30 healthy controls, we looked at the relationship between HLA-Cw6 and clinical features. We found that patients with psoriasis had significantly higher levels of HLA-Cw6 (64.5%) than controls (26.7%) (p=0.0001), with an odds ratio of 4.98 (2.04-12.15). Positive HLA-Cw6 patients had a significantly lower mean age of psoriasis onset than negative HLA-Cw6 patients. Patients with mild psoriasis (100%) were more likely to have the AA genotype, while patients with moderate to severe psoriasis (47.2% and 59.0%, respectively) and those with high PASI scores (55.1% and 54.1%, respectively) were more likely to have the TA genotype. Thus, HLA-Cw6 is a major genetic risk factor for psoriasis in Vietnamese patients, especially early-onset cases. Variations in HLA-Cw6 genotypes also affect disease severity.</p> 2023-10-16T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9689 Translation and validation of patient-oriented eczema measure in the Greek language 2023-10-11T14:09:12+00:00 Garyfallia Stefanou g_stefanou@hotmail.com Stamatios Gregoriou stamgreg@yahoo.gr Mihalis Bakakis mihalisbak@yahoo.gr Styliani Mastraftsi stmastraftsi@yahoo.com Alexandros Stratigos alstrat2@gmail.com Stathis Kontodimas sskgr@leo-pharma.com Konstantinos Sfaelos kssgr@leo-pharma.com Georgia Kourlaba g.kourlaba@uop.gr <p>Translating and validating the Greek version of the Patient Oriented Eczema Measure (POEM) was our goal. A parallel backtranslation process was used to translate POEM. A total of fiftynine adult atopic dermatitis patients were enlisted to assess validity and reliability. Through patient interviews with physicians, a questionnaire comprising demographics, POEM, and the dermatology life quality index (DLQI) was filled out. 3-7 days after the first visit, a second POEM completion was conducted. The POEM items conducted with study participants demonstrated a good level of internal consistency (Cronbach’s alpha = 0.88), and no overall floor and ceiling effects were found. There was a significant correlation between the DLQI and POEM scores (Spearman rho =0.71; p&lt;0.001). The POEM score between interviews showed an average intraclass correlation coefficient (95% confidence interval) of 0.89 (0.80, 0.94), indicating good to excellent test-retest reliability. Patient-reported outcome measures are becoming more and more common in Greece, so it’s critical to have access to Greek translations of validated instruments that are frequently used in literature.</p> 2023-10-11T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9778 Prevalence of pruritus in the elderly in an outpatient dermatologic clinic: a monocentric pilot study 2023-08-29T09:13:42+00:00 Sanja Javor sanja.javor@galliera.it Luigi Priano cesare.massone@galliera.it Antonio Anonide cesare.massone@galliera.it Cesare Massone cesare.massone@galliera.it <p>Few studies have examined pruritus in elderly patients, a common dermatological condition. The study examines pruritus prevalence and characteristics in elderly patients referred to the Dermatology Unit, at Genoa’s Galliera Hospital. The demographic characteristics of all Outpatient Clinic patients with any skin condition were examined, focusing on pruritus patients over 65. Pruritus was present in 36/262 patients (14%; M:F =20:16; mean age: 59.55 years). About 14% of 140 patients aged ≥65 years had pruritus, with 20/262 (8%; M:F =14:6; mean age: 74.6 years) exhibiting it. Visual analog score pruritus did not differ between patients aged ≥65 years (20/36) and &lt;65 years (16/36) statistically. In 89% of patients, itch was related to a dermatological condition, mainly psoriasis. Only extracutaneous diseases resulted more frequently in the patients aged &gt;65. No anamnestic link was found between drug use and pruritus in these patients. We confirm that pruritus is a common skin problem that affects both sexes, young and old, and is almost always caused by an underlying skin condition (mainly psoriasis). It is rarely caused by a new drug.</p> 2023-08-29T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9861 Correlation between serum 25(OH)D levels with severity of work-related hand eczema among healthcare workers: a cross-sectional study 2023-10-25T09:30:24+00:00 Danny Surya dannysurya.k@gmail.com Melani Marissa melani_marissa@yahoo.com Windy Keumala Budianti wkeumala@gmail.com Rahadi Rihatmadja rihatmadja@live.com Inge Ade Krisanti roro.inge@gmail.com Dewi Friska defriska@yahoo.com Sandra Widaty sandra.widaty@gmail.com <p>Hand eczema (HE) is a common condition seen in medical facilities, particularly during the COVID-19 pandemic. The effects of vitamin D on skin inflammation are diverse. The purpose of this study is to examine the relationship between vitamin D levels in healthcare workers as determined by serum 25(OH)D and the severity of HE. In Indonesia, between September and October of 2022, a cross-sectional design was employed for this analytical descriptive study. The hand eczema severity index was used to determine the severity of HE. Out of the 44 healthcare workers who had HE, the findings indicated that 29 had mild HE, 11 had moderate HE, and 4 had severe HE. Subjects with mild, moderate, and severe HE had mean serum 25(OH)D levels of 17.85 ng/mL, 16.45 ng/mL, and 17.87 ng/mL, respectively, falling into the vitamin D deficiency category. Serum 25(OH)D levels and the severity of HE did not significantly correlate (r=-0.056; p=0.359). Serum 25(OH)D levels did not significantly differ between subjects with mild, moderate, and severe HE. The degree of HE was not negatively correlated with serum 25(OH)D levels.</p> 2023-10-25T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9833 Tracing human papillomavirus in skin and mucosal squamous cell carcinoma: a histopathological retrospective survey 2024-02-01T14:32:59+00:00 Ali Nili mohammaddarvishimd@yahoo.com Maryam Daneshpazhooh mohammaddarvishimd@yahoo.com Hamidreza Mahmoudi mohammaddarvishimd@yahoo.com Kambiz Kamyab mohammaddarvishimd@yahoo.com Shirin Taraz Jamshidi mohammaddarvishimd@yahoo.com Saeed Soleiman-Meigooni mohammaddarvishimd@yahoo.com Mohammad Darvishi mohammaddarvishimd@yahoo.com <p>Worldwide, squamous cell carcinoma (SCC) incidence is rising. The literature debates the human papillomavirus (HPV)’s role in cutaneous SCC development. We examined HPV histopathology in SCC samples in this study. Retrospective study at tertiary referral skin center in 2020. Histopathological features of HPV, including koilocytosis, hyperkeratosis, acanthosis, hypergranulosis, parakeratosis, solar elastosis, papillomatosis, and tumor grade, were examined in SCC specimens. Two dermatopathologists independently reevaluated all samples. We examined 331 SCC cases (male:female ratio = 3.9:1). The mean age was 68.1, with 15.1 standard deviation. Lesions were most common on the face (40.5%), scalp (22.7%), and extremities (20.8%). Koilocytes were found in 50 (15.1%) lesions. Nail (38.1%, p=0.007), oral cavity (36.8%, p=0.014), and genitalia (60.0%, p=0.026) lesions had higher koilocytosis rates. SCCs were found in 6.6% of specimens, but in situ tumors had the highest koilocytosis (64.7%), significantly higher than other grades (p&lt;0.001). SCC pathology often shows HPV and specific koilocyte histopathology. Well-differentiated SCC has a stronger association with nail, oral, and genital lesions.</p> 2024-02-01T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9851 Analysis of pediatric outpatient visits uncovers disparities in molluscum contagiosum treatment across medical specialties in the United States 2023-10-11T14:09:09+00:00 Karan Rajalingam krajalingam2020@health.fau.edu Wei-Shen Chen weishenchen@usf.edu Ann Lin annlin@usf.edu <p>Molluscum contagiosum (MC) is a common viral infection that affects the skin of children. In this study, treatment regimens and demographic information for MC patients across US medical specialties were compared. We discovered an average of 471,383 pediatric MC visits annually using the National Ambulatory Medical Care Survey database from 2000 to 2016. Non-Hispanics (82.9%) and Caucasians (91.0%) made up the majority of the visitors. The majority of cases were handled by pediatricians (46.5%), family medicine doctors (10.6%), and dermatologists (36.7%). Compared to pediatricians, dermatologists saw a higher percentage of Caucasian patients (95% <em>vs</em>.84%) and patients with private insurance (83% <em>vs</em>. 73%). Patients were more likely to see family medicine doctors (55.0%) in non-metropolitan areas than pediatricians (26.4%) or dermatologists (16.3%). Dermatologists were less likely than pediatricians (38%) to favor spontaneous resolution (70%). Dermatologists favored terpenoids (20%), imiquimod (12%), and curettage (10%), while pediatricians primarily used terpenoids (12%), steroids (4%), and imiquimod (4%). The majority of MC cases are managed by pediatricians; however, treatment approaches deviate markedly from recommended best practices.</p> 2023-10-11T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9868 Serum interleukin-6 concentration in patients with pemphigus 2024-02-01T15:44:35+00:00 Thai Van Thanh Le anhtuanngo267@gmail.com Anh Tuan Ngo anhtuanngo267@gmail.com Quoc Hung Ta anhtuanngo267@gmail.com The Bich Thanh Vuong anhtuanngo267@gmail.com <p>Pemphigus is a rare blistering autoimmune disease that damages the integumentary system and lowers the quality of life of patients. Interleukin-6 (IL-6) has been linked to the immunopathogenesis of pemphigus, according to recent research. Thus, the investigation purpose was to assess the function of IL-6 in the development and intensity of pemphigus disease. Between January 2022 and August 2022, a case-series study involving 26 patients with pemphigus vulgaris (PV), four patients with pemphigus foliaceus (PF), and 20 healthy volunteers was carried out at the Ho Chi Minh City Hospital of Dermato-Venereology. Patients with PV and PF had significantly higher serum IL-6 concentrations than healthy volunteers (p&lt;0.001). Patients with a positive Nikolsky sign had significantly higher serum IL-6 concentrations than those with a negative sign (p&lt;0.001). The serum IL-6 concentration and the pemphigus disease area index were found to significantly correlate (r=0.8, p&lt;0.001). According to our findings, IL-6 might be a significant factor in pemphigus development and severity. Thus, novel treatments that specifically target IL-6 could be a good option for managing pemphigus, particularly in its more severe forms.</p> 2024-02-01T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9860 Sexually transmitted diseases and HIV co-infection among adult male patients in the 2022 monkeypox outbreak: a systematic review and meta-analysis 2024-02-06T11:01:08+00:00 Osama Abu-Hammad o.abuhammad@yahoo.com Diana Arabiat d.arabiat@ju.edu.jo Nebras Althagafi nthagafi@taibahu.edu.sa Rawah Eshky reshky@taibahu.edu.sa Abdalla Abu-Hammad abdullah018ju@gmail.com Abdul-Raheem Jaber abdulrahem.jabr2000@gmail.com Abdel Rahman Jaber jabrabdulrahman@gmail.com Najla Dar-Odeh najla_dar_odeh@yahoo.com <p>This meta-analysis estimates sexually transmitted disease (STI) and HIV rates in male monkeypox patients during the 2022 outbreak. The study examines contextual factors that increase monkeypox risk. A systematic review of PubMed/Medline, Scopus, and Google Scholar was conducted to find observational studies on monkeypox patients’ demographics and medical characteristics from the 2022 outbreak. This review’s meta-analysis followed the System for the Unified Management, Assessment, and Review of Information – Joanna Briggs Institute (SUMARI JBI) guidelines. All HIV and STI prevalence data for male monkeypox patients was exported into the SUMARI JBI. For point prevalence of HIV and STIs, we used the Freeman-Tukey-type arcsine square root transformation to stabilize raw proportion variances. A fixed-effects model weighted and pooled all estimates by inverse variance. We then used a random model to account for sampling variation and reported fixed-effect model effect size heterogeneity across studies. Study heterogeneity was measured using the I<sup>2</sup> test statistic and P-values. I<sup>2</sup> test results were interpreted as low (25%), moderate (50%), and high (75%). Six Spanish and English studies qualified. These studies included 541 male monkeypox patients, 214 of whom had HIV and 255 with other STIs. HIV prevalence was estimated at 40% (95% CI = 0.31%, 0.50%; ᵡ2=15) and STIs at 43% (95% CI = 25%, 61%; ᵡ2=118). Overall, analyses showed moderate to high heterogeneity. Four in ten male monkeypox patients in 2022 had HIV or other STIs. To prevent HIV and other STIs, public health measures should target male and female monkeypox patients.</p> 2024-02-06T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9839 Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 2023-09-22T09:37:16+00:00 Alba Guglielmo albaguglielmo@gmail.com Maria Ludovica Deotto marialudovica.deotto@libero.it Luigi Naldi luigi.naldi@aulss8.veneto.it Giuseppe Stinco giuseppe.stinco@uniud.it Alessandro Pileri alessandro.pileri2@unibo.it Bianca Maria Piraccini biancamaria.piraccini@unibo.it Anna Belloni Fortina anna.bellonifortina@unipd.it Andrea Sechi sechi.andre@gmail.com <p>This comprehensive review offers a detailed look at atopic dermatitis (AD) treatment in Italy, focusing primarily on the use of biologics and small molecules. In response to advancing knowledge of AD’s causes and treatments, there’s a global need for updated guidelines to provide physicians with a more comprehensive clinical perspective, facilitating personalized treatment strategies. Dupilumab, a groundbreaking biologic, gained approval as a significant milestone. Clinical trials demonstrated its ability to significantly reduce AD severity scores, with an impressive 37% of patients achieving clear or nearly clear skin within just 16 weeks of treatment. Real-world studies further support its efficacy across various age groups, including the elderly, with a safety profile akin to that of younger adults. Tralokinumab, a more recent approval, shows promise in clinical trials, particularly among younger populations. However, its real-world application, especially in older individuals, lacks comprehensive data. Janus Kinases inhibitors like Upadacitinib, Baricitinib, and Abrocitinib hold substantial potential for AD treatment. Nevertheless, data remains limited for patients over 75, with older adults perceived to carry a higher risk profile. Integrated safety analyses revealed individuals aged 60 and above experiencing major adverse cardiovascular events and malignancies, underscoring the need for cautious consideration. While these therapies offer promise, especially among younger patients, further research is essential to determine their safety and efficacy in various populations, including pediatric, geriatric, and those with comorbidities. Biologics and small molecules are improving AD treatment, as shown in this review.</p> 2023-09-13T00:00:00+00:00 Copyright (c) 2023 the Author(s) https://www.pagepress.org/journals/dr/article/view/9902 A microRNA focus on acne 2024-02-02T09:50:59+00:00 Sarah Gordon s.c.gordon@bham.ac.uk Alison M. Layton alison.layton1@nhs.net Sandra Fawcett S.A.Fawcett@ljmu.ac.uk Kehinde Ross o.k.ross@ljmu.ac.uk <p>Acne (syn. acne vulgaris) is a common inflammatory skin disorder associated with puberty and adolescence. The disease is characterized by comedoneous lesions, papules, pustules, and nodules that are mostly found on the face. These lesions are caused by intricate interactions between the pilosebaceous unit and the <em>Cutibacterium acnes</em> (<em>C. acnes</em>) bacteria. Unhealthy acne and its aftereffects, like pigment changes and scarring, have a detrimental impact on one’s quality of life. Recent years have seen a sharp increase in the approval of nucleic acid therapies (NATs), such as antisense oligonucleotides and short-interfering RNA medications, for rare diseases for which there are few or no effective treatments. These developments suggest that NATs may be useful in acne treatment plans down the road, as do clinical trials for microRNA (miRNA) modulation in skin contexts. We highlight promising miRNA targets for anti-acne therapy in this review. We outline the pathophysiology of acne in brief and emphasize the functions of <em>C. acnes</em>. Next, we concentrate on the distinct impacts of biofilm and planktonic <em>C. acnes</em> on a Toll-like receptor 2 axis that spans miR-146a-5p, which was recently discovered. Before discussing the potential contributions of miR-21- 5p, miR-233-3p, and miR-150-5p to inflammatory axes in acne, we evaluate miR-146a-5p in sebocytes. Finally, we address patient involvement in miRNA-related acne research and translational perspectives.</p> 2024-02-02T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9977 Modified advancement transposition flap for squamous cell carcinoma with periauricular location 2024-04-08T07:14:01+00:00 Georgi Tchernev georgi_tchernev@yahoo.de Simona Kordeva simonakordeva97@gmail.com <p>A 74-year-old male presented to the dermatology department with tumor formation located in the left auricle area, measuring 2 cm in size. The tumor exhibited surface erosions and periphereal erythema. Additionally, in the right lower eyelid and temporal regions, clinically suspected lesions for squamous cell carcinomas were noted. The patient had a previous history of 15 surgical interventions in the facial area, primarily for squamous cell carcinomas, with one documented removal of basal cell carcinoma. [...]</p> 2024-04-08T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9891 A spear flap surgical revision 2024-02-16T08:18:38+00:00 Ernesto De Piano ernesto.depiano@libero.it Pietro Rubegni pietro.rubegni@gmail.com Vittoria Cioppa v.cioppa@student.unisi.it <p>A 55-year-old male presented with a recurrent infiltrative basal cell carcinoma of the right nasal ala. Previous incomplete excision was repaired with second intention healing resulting in a contracted ala with columellar deviation and nostril asymmetry. [...]</p> 2024-02-16T00:00:00+00:00 Copyright (c) 2024 the Author(s) https://www.pagepress.org/journals/dr/article/view/9933 Surgical reconstruction of the temporal-zygomatic area using a mandibular Burow’s triangle advancement flap 2024-02-14T14:58:46+00:00 Laura Miccio lauramiccio@hotmail.it Fortunato Cassalia fortunato1287@gmail.com <p>A 65-year-old man was referred with two adjacent skin lesions located in the right temporal and zygomatic area. A dermoscopic examination revealed features indicative of two basal cell carcinomas, prompting the scheduling of surgical removal. [...]</p> 2024-02-14T00:00:00+00:00 Copyright (c) 2024 the Author(s)